CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 321 enrolled
Drug / intervention
CardioMEMS HF Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02954341
NCT02954341N/ACompleted
CompareCT.gov

CardioMEMS HF System OUS Post Market Study

Abbott Medical Devices·observational·Posted Nov 3, 2016·Updated Feb 24, 2025

In Brief

An observational study evaluating CardioMEMS HF System for Heart Failure and 2 related conditions. Completed, enrolled 321 participants across 5 sites in 5 countries.

Detailed Summary

The purpose of this Post Market Study (PMS) is to evaluate the use of the CardioMEMS HF System in patients with New York Heart Association (NYHA) Class III Heart Failure in a commercial setting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Left-Sided Heart Failure, Congestive Heart Failure
CountriesAustralia, Belgium, Denmark, France, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedNov 3, 2016
Enrollment StartJul 1, 2016
Primary CompletionDec 8, 2023
TodayJul 2, 2026
Enrollment to primary: 7.4 yearsPosted 9.7 years ago

Interventions

CardioMEMS HF Systemdevice